(NASDAQ: ONVO) Organovo Holdings's forecast annual revenue growth rate of 47.99% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 60.26%, and while it is forecast to beat the US market's average forecast revenue growth rate of 9.39%.
Organovo Holdings's revenue in 2024 is $242,000.On average, 1 Wall Street analysts forecast ONVO's revenue for 2025 to be $4,417,633, with the lowest ONVO revenue forecast at $4,417,633, and the highest ONVO revenue forecast at $4,417,633.
In 2026, ONVO is forecast to generate $5,321,239 in revenue, with the lowest revenue forecast at $5,321,239 and the highest revenue forecast at $5,321,239.